Keyword: generic drugmakers

News

US Generics Price Probe Nearing Climax?

15.11.2016 - The US Department of Justice (DOJ) is stepping up its broad criminal investigation into suspected price fixing for generic drugs. A Grand Jury probe in the two-year-old case is...

News

Teva to Name New Chairman?

15.07.2014 - Teva Pharmaceutical Industries board is to appoint vice-chairman Amir Elstein as its new chairman, activist shareholder Benny Landa has said. "I was informed by Moshe Many, Amir...

News

Mylan to Pay Abbott $5.3 Billion for Non-US Business

15.07.2014 - Generic drugmaker Mylan said it plans to acquire Abbott Laboratories' branded specialty and generics business in developed markets outside the US for $5.3 billion. Both companies...

News

Generic Drugmakers Ramp up Campaign Against FDA Label Plan

03.03.2014 - Generic drugmakers are actively campaigning against a rule proposed by the U.S. Food and Drug Administration (FDA) that would require them to change the prescribing information on...

News

Teva, Sun Pharma to Pay $2.15 Billion to Settle Pfizer Patent Suit

12.06.2013 - Pfizer said Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries would pay $2.15 billion to settle a patent suit related to its acid-reflux drug. This is the first...

News

After Tech Success, Israel Seeks Life Sciences Growth

06.06.2013 - Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences. The Mediterranean country already boasts the world's...

News

EU to Fine Lundbeck, Others for Blocking Generic Drugs

03.06.2013 - A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said...

News

India's Sun Pharma in Talks to Buy Sweden's Meda for $5-$6 Billion

01.06.2013 - India's Sun Pharmaceutical Industries is in talks to buy Sweden's Meda for between $5 billion and $6 billion to boost its generics business in developed markets, two sources with...